Monoclonal Antibody Diagnostic Reagents Market, By Diagnostic Tests (Double Antigen Sandwich Chemiluminescence Method, Dot-immunogold Filtration Assay, and Recombinant Immunoblot Assay, Enzyme Linked Immunosorbent Assay), By Application (Tumor Monitoring, Hormones Diagnosis, Virus Detection, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Trends, Analysis and Forecast till 2034

Monoclonal antibody diagnostic reagents market was estimated to be worth US$ 8.5 billion in 2024 and is expected to increase to US$ 27.2 billion by 2034, growing at a CAGR of 12.3%.

For numerous uses, such as flow cytometric analysis, immunoprecipitation, the enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry, antibodies are a necessary instrument. Additionally, monoclonal antibodies, or MAbs, are an important diagnostic tool used in biomedical and microbiological research as well as for the treatment of cancer and the diagnosis of a number of diseases, including hepatitis, HIV, herpes simplex, influenza infections, and chlamydia. Consequently, it is anticipated to propel the growth of the Monoclonal Antibody Diagnostic Reagents Market during the forecast period due to its significance in the clinical application.